IL156532A0 - Lipid microparticles, their preparation and pharmaceutical compositions containing them - Google Patents
Lipid microparticles, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL156532A0 IL156532A0 IL15653201A IL15653201A IL156532A0 IL 156532 A0 IL156532 A0 IL 156532A0 IL 15653201 A IL15653201 A IL 15653201A IL 15653201 A IL15653201 A IL 15653201A IL 156532 A0 IL156532 A0 IL 156532A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- lipid microparticles
- microparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00128556 | 2000-12-27 | ||
EP01125741 | 2001-10-26 | ||
PCT/EP2001/014890 WO2002051386A2 (fr) | 2000-12-27 | 2001-12-17 | Microparticules lipidiques obtenues par micronisation cryogenique |
Publications (1)
Publication Number | Publication Date |
---|---|
IL156532A0 true IL156532A0 (en) | 2004-01-04 |
Family
ID=26071690
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15653201A IL156532A0 (en) | 2000-12-27 | 2001-12-17 | Lipid microparticles, their preparation and pharmaceutical compositions containing them |
IL156532A IL156532A (en) | 2000-12-27 | 2003-06-19 | Lipid microchips, their preparation and pharmaceutical preparations containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL156532A IL156532A (en) | 2000-12-27 | 2003-06-19 | Lipid microchips, their preparation and pharmaceutical preparations containing them |
Country Status (12)
Country | Link |
---|---|
US (1) | US7704525B2 (fr) |
JP (1) | JP4748923B2 (fr) |
AR (1) | AR032074A1 (fr) |
AT (1) | ATE373471T1 (fr) |
AU (1) | AU2002219198B2 (fr) |
CA (1) | CA2431890C (fr) |
DE (1) | DE60130580T2 (fr) |
DK (1) | DK1345593T3 (fr) |
ES (1) | ES2290095T3 (fr) |
IL (2) | IL156532A0 (fr) |
PT (1) | PT1345593E (fr) |
WO (1) | WO2002051386A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
JP2005504090A (ja) | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
EP1748788A1 (fr) | 2004-05-17 | 2007-02-07 | Ares Trading S.A. | Formulations hydrogel contenant un interferon |
MXPA06014078A (es) | 2004-06-01 | 2007-02-15 | Ares Trading Sa | Formulaciones liquidas estabilizadas de interferon. |
PL2234645T3 (pl) | 2007-12-20 | 2012-10-31 | Merck Serono Sa | Preparaty interferonu-beta modyfikowanego PEG |
WO2012059936A1 (fr) | 2010-11-03 | 2012-05-10 | Padma Venkitachalam Devarajan | Compositions pharmaceutiques destinées à l'administration de médicaments colloïdaux |
JP6014656B2 (ja) * | 2011-05-18 | 2016-10-25 | ラビラトリオス レスビ エス エレ | 化合物の多形体 |
DE102013224627A1 (de) | 2013-11-29 | 2015-06-03 | Andreas Lauterbach | Pharmazeutische Formulierung mit Lipidmikropartikeln und Herstellungsverfahren |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3024416C2 (de) | 1980-06-28 | 1982-04-15 | Gödecke AG, 1000 Berlin | Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung |
US4610868A (en) | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
US4837381A (en) | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
DE3777721D1 (de) * | 1986-08-11 | 1992-04-30 | American Cyanamid Co | Zusammensetzungen zur parenteralen verabreichung und deren verwendung. |
US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
GB2209937B (en) | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
IE904098A1 (en) * | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
AU658608B2 (en) * | 1991-03-25 | 1995-04-27 | Astellas Pharma Europe B.V. | Topical preparation containing a suspension of solid lipid particles |
AU692506B2 (en) * | 1993-11-17 | 1998-06-11 | Ibah, Inc. | Transparent liquid for encapsulated drug delivery |
US5430021A (en) | 1994-03-18 | 1995-07-04 | Pharmavene, Inc. | Hydrophobic drug delivery systems |
DE19819273A1 (de) | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung |
-
2001
- 2001-12-17 CA CA2431890A patent/CA2431890C/fr not_active Expired - Fee Related
- 2001-12-17 DK DK01272020T patent/DK1345593T3/da active
- 2001-12-17 JP JP2002552532A patent/JP4748923B2/ja not_active Expired - Fee Related
- 2001-12-17 ES ES01272020T patent/ES2290095T3/es not_active Expired - Lifetime
- 2001-12-17 US US10/451,676 patent/US7704525B2/en not_active Expired - Fee Related
- 2001-12-17 AT AT01272020T patent/ATE373471T1/de active
- 2001-12-17 WO PCT/EP2001/014890 patent/WO2002051386A2/fr active IP Right Grant
- 2001-12-17 PT PT01272020T patent/PT1345593E/pt unknown
- 2001-12-17 DE DE60130580T patent/DE60130580T2/de not_active Expired - Lifetime
- 2001-12-17 AU AU2002219198A patent/AU2002219198B2/en not_active Ceased
- 2001-12-17 IL IL15653201A patent/IL156532A0/xx unknown
- 2001-12-27 AR ARP010106067A patent/AR032074A1/es active IP Right Grant
-
2003
- 2003-06-19 IL IL156532A patent/IL156532A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2002051386A2 (fr) | 2002-07-04 |
US20040091522A1 (en) | 2004-05-13 |
PT1345593E (pt) | 2007-10-10 |
ES2290095T3 (es) | 2008-02-16 |
WO2002051386A3 (fr) | 2002-10-10 |
AU2002219198B2 (en) | 2006-06-29 |
AR032074A1 (es) | 2003-10-22 |
JP2004529864A (ja) | 2004-09-30 |
ATE373471T1 (de) | 2007-10-15 |
JP4748923B2 (ja) | 2011-08-17 |
IL156532A (en) | 2011-04-28 |
CA2431890C (fr) | 2011-05-10 |
CA2431890A1 (fr) | 2002-07-04 |
DK1345593T3 (da) | 2007-12-10 |
DE60130580D1 (de) | 2007-10-31 |
DE60130580T2 (de) | 2008-06-12 |
US7704525B2 (en) | 2010-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL156531A0 (en) | Lipid nanoparticles, their preparation and pharmaceutical compositions containing them | |
IL151209A0 (en) | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation | |
IL154965A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
DZ3313A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
IL148876A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
IL151912A0 (en) | Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them | |
HUP0302515A3 (en) | Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them | |
IL156532A0 (en) | Lipid microparticles, their preparation and pharmaceutical compositions containing them | |
IL154966A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0303204A3 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing them | |
HUP0401713A3 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
HUP0300330A3 (en) | Oligosaccharides, pharmaceutical compositions containing them and preparation thereof | |
HUP0302905A3 (en) | Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them | |
IL151715A0 (en) | N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them | |
SI1215213T1 (sl) | Biciklicni derivati amino-pirazonov, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo | |
HUP0303688A3 (en) | Propanolaminotetralines, preparation thereof and pharmaceutical compositions containing same | |
IL135707A0 (en) | 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |